New legislation and guidelines for medical communications

January 21, 2009 at 7:37 pm 1 comment

A great overview on the global implications of FDAAA Legislation, as written by Liz Wager, is now accessible at the website. The follow-on to Liz’s first Good Publication Practice Guidelines, the so-called GPP2 are in development, as discussed in an article in Pharmaceutical Marketing Europe, January/February 2009 issue. I can’t see it yet on the website ( but it may appear soon.

Further to Jane MacDougall’s comment, you can find Liz’s article: Medical Writers and Peer-Reviewed Journals: Understanding the Rules and Responsibilities here.


Entry filed under: Clinical trials, Good Publication Practice, Medical writers, Medical writing, Pharmaceutical, Writing tools, tips and updates.


1 Comment Add your own

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

Trackback this post  |  Subscribe to the comments via RSS Feed



Previously on Medical Communicating…


%d bloggers like this: